Stazzone Peter
SEC insider (Form 3/4/5 filer). CIK 0002083297. Chief Financial Officer at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in BOCA RATON, FL.
Companies Stazzone Peter has filed insider reports for
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT): Officer, Chief Financial Officer
Stazzone Peter
CIK: 0002083297
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 1, 2026LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirect50K shares- - Apr 15, 2026LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirect50K shares- - Apr 15, 2026LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
DispositionDirectOptions to Purchase Common Stock
50K shares- - Sep 1, 2025LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirectOptions to Purchase Common Stock
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award | 50,000 | - | $0 | Direct |
| Apr 15, 2026 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award | 50,000 | - | $0 | Direct |
| Apr 15, 2026 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Disposition Options to Purchase Common Stock | 50,000 | - | - | Direct |
| Sep 1, 2025 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award Options to Purchase Common Stock | 50,000 | - | - | Direct |
1-4 of 4 transactions